{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:53:40Z","timestamp":1761238420977,"version":"build-2065373602"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present paper summarizes highlights in the field of glomerular diseases presented at the 2015 European Renal Association congress in London. Topics covered include a European survey on renal biopsy practice and indications, the STOP-IgAN randomized controlled trial in patients with IgA-nephropathy, B-cell- targeting therapies in minimal change nephropathy and focal segmental glomerulosclerosis (FSGS), novel insights into the action of glucocorticosteroids in glomerular crescent and scar (FSGS) formation, the immunoproteasome in IgA-nephropathy, socio-economic factors and glomerular disease progression, glomerular CD80 (B7-1) expression in FSGS patients and aldosterone-antagonism in proteinuric renal diseases.<\/jats:p>","DOI":"10.1093\/ndt\/gfv433","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T03:12:10Z","timestamp":1452741130000},"page":"177-180","source":"Crossref","is-referenced-by-count":0,"title":["Highlights of the 2015 ERA-EDTA Congress\u2014glomerular diseases"],"prefix":"10.1093","volume":"31","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[{"name":"University Hospital, Rheinisch Westf\u00e4lische Technische Hochschule (RWTH) Department of Nephrology and Clinical Immunology , , Aachen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"article-title":"European survey on renal biopsy procedures in adults","year":"2015","author":"Amore","key":"2025102312482177900_GFV433C1"},{"key":"2025102312482177900_GFV433C2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.ASN.0000102472.37947.14","article-title":"Timing of complications in percutaneous renal biopsy","volume":"15","author":"Whittier","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025102312482177900_GFV433C3","first-page":"284","article-title":"Supportive versus immunosuppressive therapy of progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol","volume":"21","author":"Eitner","year":"2008","journal-title":"J Nephrol"},{"key":"2025102312482177900_GFV433C4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"2025102312482177900_GFV433C5","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","article-title":"Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy","volume":"24","author":"Manno","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312482177900_GFV433C6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","article-title":"Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial","volume":"53","author":"Lv","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2025102312482177900_GFV433C7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","article-title":"Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy","volume":"13","author":"Ballardie","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2025102312482177900_GFV433C8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial","volume":"15","author":"Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025102312482177900_GFV433C9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/gft312","article-title":"Rituximab for minimal change disease in adults: long-term follow-up","volume":"29","author":"Bruchfeld","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312482177900_GFV433C10","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025102312482177900_GFV433C11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMc1308488","article-title":"Ofatumumab for rituximab-resistant nephrotic syndrome","volume":"370","author":"Basu","year":"2014","journal-title":"N Engl J Med"},{"article-title":"Unraveling the mechanism of action of glucocorticoids in glomerulonephritis","year":"2015","author":"Kuppe","key":"2025102312482177900_GFV433C12"},{"key":"2025102312482177900_GFV433C13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrneph.2014.1","article-title":"The emergence of the glomerular parietal epithelial cell","volume":"10","author":"Shankland","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2025102312482177900_GFV433C14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"2025102312482177900_GFV433C15","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv171.01","article-title":"The proteasome to immunoproteasome switch in IgA nephropathy and its genetic control: a post-VALIGA European research study","author":"Peruzzi","year":"2015"},{"key":"2025102312482177900_GFV433C16","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv171.23","article-title":"The influence of socioeconomic deprivation on outcomes in patients with primary glomerulopathies","author":"McQuarrie","year":"2015"},{"key":"2025102312482177900_GFV433C17","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"2025102312482177900_GFV433C18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMc1400502","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"370","author":"Benigni","year":"2014","journal-title":"N Engl J Med"},{"article-title":"Detection of glomerular CD80 (B7-1) mRNA by qrt-PCR and on podocytes by immunostaining on paraffin embedded biopsies with FSGS","year":"2015","author":"Becker","key":"2025102312482177900_GFV433C19"},{"article-title":"Two years follow-up of antiproteinuric effect o addition of eplerenone to ACE inhibitors or ARBs in non-nephrotic glomerular diseases","year":"2015","author":"Arroyo","key":"2025102312482177900_GFV433C20"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/31\/2\/177\/7430240\/gfv433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/31\/2\/177\/7430240\/gfv433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:48:47Z","timestamp":1761238127000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/31\/2\/177\/2460139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,12]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfv433","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"type":"electronic","value":"1460-2385"},{"type":"print","value":"0931-0509"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2016,1,12]]}}}